Effects of angiotensin II type 1 receptor blockade and angiotensin- converting enzyme inhibition on cardiac β-adrenergic signal transduction

Hypertension

Volumn 31, Issue 3, 1998, Pages 747-754

  Böhm, Michael ^a   Zolk, Oliver ^a   Flesch, Markus ^a   Schiffer, Frank ^a   Schnabel, Petra ^a   Stasch, Johannes Peter ^b   Knorr, Andreas ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BAYER AG   (Germany)

Author keywords

Adrenoceptors; Angiotensin receptor subtypes; Catecholamines; G proteins; Hypertrophy

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EMBUSARTAN; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE Y; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SYSTEMATIC DESENSITIZATION; TRANSGENIC ANIMAL;

EID: 4243242661     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.747     Document Type: Article

References (56)

1. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988;77:721-730.
2. Swedberg K, Viquerat C, Rouleau J-L, Roizen M, Atherton B, Parmley WW, Chatterjee K. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol. 1984;54:783-789.
3. Dzau VJ, Hirsch A. Emerging role of tissue renin-angiotensin systems in congestive heart failure. Eur Heart J. 1990;11:65-71.
4. Hirsch AC, Talsness C, Schunkert H, Paul M, Dzau V. Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
5. Isaacson JS, Reid IA. Importance of endogenous angiotensin II in the cardiovascular responses to sympathetic stimulation in conscious rabbits. Circ Res. 1990;66:662-671.
6. Gilbert EM, Sandoval A, Larrabee P, Renlund DG, O'Connel JB, Bristow MR. Lisinopril lowers cardiac adrenergic drive and increases β-receptor density in the failing human heart. Circulation. 1993;88:472-480.
7. Böhm M, Gräbel C, Knorr A, Erdmann E. Treatment in hypertensive cardiac hypertrophy, I. Hypertension. 1995;25:954-961.
8. Böhm M, Gräbel C, Flesch M, Knorr A, Erdmann E. Treatment in hypertensive cardiac hypertrophy, II. Hypertension. 1995;25:962-970.
9. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
10. Böhm M, Moll M, Schmid B, Paul M, Ganten D, Castellano M, Erdmann E. β-Adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats. Hypertension. 1994;24:653-662.
11. Bristow MR, Ginsburg R, Minobe W, Cibiccioti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
12. 2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev. 1991;43: 203-242.
13. Böhm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J. 1988;9:844-852.
14. Böhm M, Gierschik P, Jakobs KH, Pieske B, Schnabel P, Ungerer M, Erdmann E. Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 1990;82:1249-1265.
15. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest. 1988;82:189-197.
16. Neumann J, Schmitz W, v Meyerinck L, Scholz H, Döring V, Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet. 1988;2: 936-937.
17. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Ann Biochem. 1974;58:541-548.
18. iα. Mol Pharmacol. 1994;45:380-389.
19. Goldsmith P, Gierschik P, Milligan G, Unson CG, Vinitsky R, Marech HL, Spiegel AM. Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem. 197;262:14683-14688.
20. Böhm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M, Erdmann E. Radioimmunochemical quantification of Giα in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol. 1994;26:133-149.
21. Sternweis PC, Northup JK, Smigel MD, Gilman AG. The regulatory component of adenylate cyclase. J Biol Chem. 1981;256:11517-11526.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
23. Oikawa S, Imai M, Ueno A, Tanaka S, Noguchi T, Nakazato H, Kangawa K, Fukada A, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human atrial natriuretic polypeptide. Nature. 1984;309: 724-726.
24. Jones DT, Reed RR. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithehum. J Biol Chem. 1987;262: 14241-14249.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
26. Läemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
27. Stasch JP, Knorr A, Hirth-Dietrich C, Krämer T, Hübsch W, Sander E, Frobel K, Kazda S. Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats and stroke-prone spontaneously hypertensive rats. Naunyn-Schmiedebergs Arch Pharmacol. 1996;353(suppl 4):R69. Abstract.
28. 1-selective angiotensin II (AII) receptor antagonist. Naunyn-Schmiedebergs Arch Pharmacol. 1996;353(Suppl4):R65. Abstract.
29. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
30. Zimmermann BG. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci. 1981;60:343-348.
31. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1-24.
32. Purjeranta M, Rechardt L, Pelto-Huikko M, Kyosola K. Light and electron microscopic demonstration of neuropeptide Y-like immunoreactive nerves in human cardiac muscle. Virchows Arch A Pathol Anat Histopathol. 1986;410:147-151.
33. Morris MJ, Elliot JM, Cain MD, Kappor V, West MJ, Chalmers JP. Plasma neuropeptide Y levels rise in patients undergoing exercise tests for the investigation of chest pain. Clin Exp Pharmacol Physiol. 1986;13:437-440.
34. Maisel AS, Scott NA, Motulsky HJ, Michel MC, Boublik JH, Rivier JE, Ziegler M, Allen RS, Brown MR. Elevation of plasma neuropeptide Y levels in congestive heart failure. Am J Med. 1989;86:43-48.
35. Seamon KB, Daly JW. Forskolin: its biological and chemical properties. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1989;20:1-150.
36. Cech SY, Broaddus WC, Maguire ME. Adenylate cyclase: the role of magnesium and other divalent cations. Mol Cell Biochem. 1980;33:67-92.
37. Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension. 1990;16:107-120.
38. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, Erdmann E. Role of altered G-protein expression in the regulation of myocardial adenylate cyclase activity and force of contraction in spontaneously hypertensive cardiomyopathy in rats. J Hypertens. 1992;10:1115-1128.
39. Thibault C, Anand-Srivastava MB. Altered expression of G-protein mRNA in spontaneously hypertensive rats. FEBS Lett. 1992;313:160-164.
40. Böhm M, Gierschik P, Knorr A, Larisch K, Weismann K, Erdmann E. Desensitization of adenylate cyclase and increase of Giα in cardiac hypertrophy due to acquired hypertension. Hypertension. 1992;20:103-112.
41. Ayobe MH, Tarazi RC. Reversal of changes in myocardial β-receptors and inotropic responsiveness with regression of cardiac hypertrophy in renal hypertensive rats (RHR). Circ Res. 1984;54:125-134.
42. Woodcock EA, Funder JW, Johnston CI. Decreased cardiac β-adrenergic receptors in deoxycorticosterone-salt and renal hypertensive rats. Circ Res. 1979;45:560-565.
43. Böhm M, Gierschik P, Knorr A, Schmidt U, Weismann K, Erdmann E. Cardiac adenylyl cyclase, β-adrenergic receptors, and G proteins in salt-sensitive hypertension. Hypertension. 1993;22:715-727.
44. 2-Adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res. 1994;74:434-440.
45. Henegar JR, Brower GL, Kabour A, Janicki JS. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol. 1995;269 (Heart Circ Physiol 38):H1564-H1569.
46. Henegar JR, Brower GL, Kabour A, Janicki JS. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol. 1995;269 (Heart Circ Physiol 38):H1564-H1569.
47. Böhm M, Castellano M, Agabiti-Rosei E, Flesch M, Paul M, Erdmann E. Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and β-adrenergic signal transduction. Circulation. 1995;92:3006-3013.
48. Sanbe A, Takeo S. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuate the loss of cardiac β-adrenoceptor responses in rats with chronic heart failure. Circulation. 1995;92:2666-2675.
49. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of β-adrenergic receptor function. FASEB J. 1990;4:2881-2889.
50. oα mRNA levels and pertussis toxin-sensitive guanine nucleotide binding proteins in rat heart. Mol Pharmacol. 1992;42:773-783.
51. Müller FU, Boheler KR, Eschenhagen T, Schmitz W, Scholz H. Isoprenaline stimulates gene transcription of the inhibitory G-protein alpha-subunit Gi-alpha-2 in rat heart. Circ Res. 1993;72:696-700.
52. Urata H, Ganten D. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase. Eur Heart J. 1993;14(suppl I):177-182.
53. Schunkert HB, Jackson SS, Tang FJ, Schoen JFM, Smits CS, Apstein BH, Lorell BH. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts. Circulation. 1993;87: 1328-1339.
54. Zisman LZ, Abraham WT, Meixell GE, Vamvakies BN, Quaife RA, Lowes BD, Roden RL, Peacock SJ, Groves BM, Raynolds MV, Bristow MR, Perryman MB. Angiotensin II formation in the human heart. J Clin Invest. 1995;96:1490-1498.
55. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in rat. Circulation. 1994;89:2273-2282.
56. Stewart J. Roles for kinins in inflammation. In: Henson P, Murphy R, eds. Handbook of Inflammation, Vol 6: Mediators of the Inflammatory Process. New York, NY: Elsevier Science Publishing Co; 1989:189-217.